Public Offer vs International Placing: What Retail Investors Should Actually Know

The Hong Kong Public Offer is the part of the IPO made available through the public subscription channel. This is the bit most retail investors watch because it’s the normal way to apply for new shares through a bank, broker, or the share registrar’s electronic channel.

In practice, you usually have two main routes. IFEC explains that investors can subscribe through the share registrar’s White Form eIPO, or through HKSCC EIPO via an intermediary such as a broker or bank. With White Form eIPO, successful shares are issued in your own name. With HKSCC EIPO, the shares are credited to your securities account through your intermediary.

For most small players, this is the familiar process: choose the IPO, select how many shares or lots to apply for, pay the application money, then wait for the allotment result. Straightforward enough on the screen. Less straightforward when everyone else is pressing the same button.

Applying through the public offer never means you’re guaranteed shares. If the deal is heavily oversubscribed, you may get fewer shares than you applied for, just one board lot, or zero. I know that feels annoying, but that’s how the allocation game works.

International Placing, sometimes called the international offer or placing tranche, is mainly for institutional, professional or selected investors. Think asset managers, funds, insurance companies, hedge funds, family offices, private banks and other large accounts.

This is not usually a simple ‘click apply’ channel for mum-and-dad investors. It is handled by the underwriters, overall coordinators and investment banks through bookbuilding. In plain English, the banks go out and ask large investors how much they want, at what valuation, and how strong their interest really is.

Frankly, this part matters more than many beginners think. If institutions are willing to take a large amount of shares, especially near the top of the price range, it can support pricing and sentiment. If the placing side is weak, I’d be more cautious, even if the public offer looks noisy.

A Hong Kong IPO uses both channels because different investors do different jobs. The public offer gives ordinary investors access and creates broad market participation. The placing tranche helps with price discovery, because institutions are expected to do deeper analysis before committing larger sums.

That doesn’t mean institutions are always right. They’re not. But their demand is useful information. If the public offer is full of hype while the placing tranche is only lukewarm, that’s a signal worth noticing.

HKEX has said its changes to IPO allocation and clawback are meant to improve the balance between the placing tranche and the public subscription tranche, and to improve price discovery. In my experience, that balance matters. Too much public frenzy without serious institutional support can make the first trading day very jumpy.

A lot of older IPO explainers still talk as if every Hong Kong IPO starts with 10% for the public offer and 90% for placing. That’s too lazy now. You need to read the ‘Structure and Conditions of the Global Offering’ section in the prospectus.

Under HKEX’s current framework for listing documents published on or after 4 August 2025, an IPO with both a placing tranche and a public subscription tranche can use either Mechanism A or Mechanism B.

Under Mechanism A, the initial allocation to the public subscription tranche is 5%. If public demand is strong enough, clawback can increase the public tranche to 15%, 25% or 35%, depending on the oversubscription level. Under Mechanism B, the public subscription tranche starts with at least 10%, can be as high as 60%, and there is no clawback mechanism.

That last part is important. Don’t assume the public allocation will automatically jump just because the IPO is hot. The mechanism chosen by the issuer makes a real difference.

The clawback mechanism is one of those IPO terms that sounds complicated but is actually easy to understand once you’ve applied for a few deals.

Under Mechanism A, if the public offer is oversubscribed by at least 15 times but less than 50 times, the public tranche can increase to 15%. If demand reaches 50 times but is less than 100 times, it can increase to 25%. If demand reaches 100 times or more, it can increase to 35%.

So yes, clawback can move more shares from the placing tranche to the public subscription tranche. That sounds good for regular investors. But here’s the catch: when an IPO is 100 times subscribed, the crowd is usually huge. Even after clawback, the one-lot success rate can still be painfully low.

In other words, clawback increases the public pool, but it doesn’t magically make everyone a winner. The allotment basis still depends on how many valid applications are chasing the available shares.

Most ordinary investors apply through the public offer, not international placing. Some professional investors, private bank clients or eligible broker clients may be able to express interest in the placing tranche, depending on the IPO and their status.

But don’t try to be clever by applying in more than one place. HKEX’s updated rules allow investors to select whether to apply in the placing tranche or the public subscription tranche, but an investor may receive shares in only one of them. Issuers are also required to reject multiple applications within or between pools.

IFEC also reminds investors that duplicate applications will be rejected. For normal retail investors, the safest rule is simple: one IPO, one application under your name. Don’t use multiple brokers and hope the system won’t notice. It’s not worth the risk.

After the subscription period closes, the company, sponsor, underwriters and share registrar work out the allocation. The registrar screens out invalid, incomplete or duplicate applications. Then the valid applications are allocated according to the basis of allotment.

This is where many beginners get disappointed. A popular IPO can have a massive subscription multiple, but that doesn’t mean you’ll get a big allocation. Often, the more popular the IPO, the lower your realistic chance of getting meaningful shares.

For small investors, the one-lot success rate is usually more practical than the headline oversubscription number. A 200-times subscription sounds exciting, but if the one-lot success rate is tiny, the practical value may be limited unless you’re applying with a very specific strategy.

Even if you only apply through the public offer, the international placing still gives useful clues.

First, it can affect pricing. If institutional demand is strong, the IPO may price at the top of the range. If demand is weak, pricing may be softer, or the deal may feel less convincing.

Second, investor quality matters. Cornerstone investors or respected institutions can help sentiment, but don’t treat their names as a guarantee. Big names can be wrong, and cornerstone lock-ups don’t protect you from paying too much.

Third, the final split between public offer and placing tells you where the demand really came from. I prefer IPOs where both public demand and institutional demand look healthy. If only one side is strong, I’d slow down and read more carefully.

Before applying for a Hong Kong IPO, I’d check a few things.

First, look at the public offer size. How many shares are initially available to the public? Is the IPO using Mechanism A or Mechanism B? If it uses Mechanism A, what clawback levels apply?

Second, check the public subscription level and expected allotment. A high multiple means the IPO is hot, but it also means your chance of getting shares may be lower.

Third, look at the international placing result. Was it well covered? Were there cornerstone investors? Was the final price fixed at the top, middle or bottom of the offer price range?

Fourth, count your own costs. Brokerage fees, transaction charges and margin interest all matter. A small first-day pop may look nice on the app, but after costs, it may not be much. If you use margin, the breakeven point is higher than you think.

Finally, read the prospectus for special structures. Chapter 18C specialist technology companies, biotech issuers, weighted voting rights companies and other special cases can have details that don’t fit a simple beginner formula. The prospectus and the allotment announcement are still the final source of truth.

The Hong Kong Public Offer and International Placing are two different parts of the same IPO. The public offer is the main route for regular investors like us. The international placing is mainly for institutions and professional investors.

The thing is, a good IPO decision should look at both sides. Public demand tells you how excited the crowd is. International placing tells you how the bigger, more professional money views the deal. Clawback and allotment tell you how much stock may actually reach small investors.

My view is simple: don’t apply just because the public subscription multiple looks huge. Check the mechanism, the placing demand, the final offer price, the allotment basis, and the company’s fundamentals. IPO investing is not just ‘drawing new shares’. It’s still investing your own money.